I atosibangruppen skete to af dødsfaldene da de nyfødte var henholdsvis fem og otte måneder gamle.
In a placebo-controlled study, fetal/ infant deaths were 5/ 295 (1.7%) in the placebo group and 15/ 288 (5.2%) in the atosiban group, of which two occurred at five and eight months of age.